RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Yijing Capital
Y

Yijing Capital portfolio

Yijing Capital has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $38.41M.
Latest deal: eTheRNA Immunotherapies · Jun 16, 2020.
About this page

Its most recent investment on record is eTheRNA Immunotherapies's $38.41M Series B+ round in June 2020, alongside LSP, Fund+, Boehringer Ingelheim Venture Fund and 5 others. By category, its portfolio leans toward Health and bio (2).

What Yijing Capital invests in

How Yijing Capital invests

StageDealsCapital in rounds
Series B+ 1 100%$38.41M

Yijing Capital portfolio companies

CompanyRound with Yijing CapitalTotal raisedLatest raise
EeTheRNA Immunotherapies
Health and bio
Series B+ · $38.41M$104.41MAug 24, 2022
Series B+
AArnatar Therapeutics
Health and bio
backer$102MMar 14, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Yijing Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Yijing Capital, which is a subset of its real portfolio. API: /api/v1/investors/yijing-capital (get a free API key). More: the most active VC firms and new venture capital funds.